Thrombotic thrombocytopenic purpura: a Trojan horse of acute leukemia?: a case report
Authors:
Open Access
- 21 January 2026
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Abstract
Thrombotic thrombocytopenic purpura is a rare and life-threatening hematologic disorder. We present the case of a 66-year-old man who developed acquired thKeywords
This publication has 17 references indexed in Scilit:
- Microangiopathie thrombotique en médecine interne : étude de 39 casLa Revue de Médecine Interne, 2021
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysisJournal of Infection, 2020
- Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 2019
- Clinical and laboratory diagnosis of TTP: an integrated approachHematology-American Society Hematology Education Program, 2018
- Thrombotic thrombocytopenic purpuraNature Reviews Disease Primers, 2017
- The PLASMIC score for thrombotic thrombocytopenic purpuraThe Lancet Haematology, 2017
- Reduced ADAMTS-13 level negatively correlates with inflammation factors in plasma of acute myeloid leukemia patientsLeukemia Research, 2016
- Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathyThe Lancet Haematology, 2016
- Syndromes of Thrombotic MicroangiopathyNew England Journal of Medicine, 2014
- Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathiesBritish Journal of Haematology, 2012